MDLZ
28
4
FITB
72
2
PLD
33
3
EXC
53
3
BK
77
2
MHK
50
2
NKE
36
6
MMC
60
3
ALLE
48
2
EXPD
48
-2
ES
50
3
DRI
64
4
AAPL
55
2
JNJ
54
3
KO
44
2
CNP
55
3
KIM
56
5
LH
48
2
DVN
40
-2
HOG
38
2
MDLZ
28
4
FITB
72
2
PLD
33
3
EXC
53
3
BK
77
2
MHK
50
2
NKE
36
6
MMC
60
3
ALLE
48
2
EXPD
48
-2
ES
50
3
DRI
64
4
AAPL
55
2
JNJ
54
3
KO
44
2
CNP
55
3
KIM
56
5
LH
48
2
DVN
40
-2
HOG
38
2
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
49

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$83.89
Seasonality Move:
-0.05%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
49
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.90. The Score for VCIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

  • The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $83.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 20.67 Buy
Relative Strength Index (14 RSI): 50.4 Buy
Chaikin Money Flow: 3987788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.68 - 84.22) Sell
Bollinger Bands (100): (83.37 - 84.37) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.78 Buy
20-day SMA: 83.97 Sell
50-day SMA: 84.06 Sell
200-day SMA: 82.69 Buy
8-day EMA: 59.92 Buy
20-day EMA: 32.98 Buy
50-day EMA: 15.19 Buy
200-day EMA: 4.09 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):